Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;34(1):17-60.
doi: 10.1007/s00134-007-0934-2. Epub 2007 Dec 4.

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

R Phillip Dellinger  1 , Mitchell M Levy, Jean M Carlet, Julian Bion, Margaret M Parker, Roman Jaeschke, Konrad Reinhart, Derek C Angus, Christian Brun-Buisson, Richard Beale, Thierry Calandra, Jean-Francois Dhainaut, Herwig Gerlach, Maurene Harvey, John J Marini, John Marshall, Marco Ranieri, Graham Ramsay, Jonathan Sevransky, B Taylor Thompson, Sean Townsend, Jeffrey S Vender, Janice L Zimmerman, Jean-Louis Vincent
Affiliations

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

R Phillip Dellinger et al. Intensive Care Med. 2008 Jan.

Erratum in

  • Intensive Care Med. 2008 Apr;34(4):783-5

Abstract

Objective: To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock," published in 2004.

Design: Modified Delphi method with a consensus conference of 55 international experts, several subsequent meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee. This process was conducted independently of any industry funding.

Methods: We used the GRADE system to guide assessment of quality of evidence from high (A) to very low (D) and to determine the strength of recommendations. A strong recommendation indicates that an intervention's desirable effects clearly outweigh its undesirable effects (risk, burden, cost), or clearly do not. Weak recommendations indicate that the tradeoff between desirable and undesirable effects is less clear. The grade of strong or weak is considered of greater clinical importance than a difference in letter level of quality of evidence. In areas without complete agreement, a formal process of resolution was developed and applied. Recommendations are grouped into those directly targeting severe sepsis, recommendations targeting general care of the critically ill patient that are considered high priority in severe sepsis, and pediatric considerations.

Results: Key recommendations, listed by category, include: early goal-directed resuscitation of the septic patient during the first 6 hrs after recognition (1C); blood cultures prior to antibiotic therapy (1C); imaging studies performed promptly to confirm potential source of infection (1C); administration of broad-spectrum antibiotic therapy within 1 hr of diagnosis of septic shock (1B) and severe sepsis without septic shock (1D); reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate (1C); a usual 7-10 days of antibiotic therapy guided by clinical response (1D); source control with attention to the balance of risks and benefits of the chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid challenge to restore mean circulating filling pressure (1C); reduction in rate of fluid administration with rising filing pressures and no improvement in tissue perfusion (1D); vasopressor preference for norepinephrine or dopamine to maintain an initial target of mean arterial pressure > or = 65 mm Hg (1C); dobutamine inotropic therapy when cardiac output remains low despite fluid resuscitation and combined inotropic/vasopressor therapy (1C); stress-dose steroid therapy given only in septic shock after blood pressure is identified to be poorly responsive to fluid and vasopressor therapy (2C); recombinant activated protein C in patients with severe sepsis and clinical assessment of high risk for death (2B except 2C for post-operative patients). In the absence of tissue hypoperfusion, coronary artery disease, or acute hemorrhage, target a hemoglobin of 7-9 g/dL (1B); a low tidal volume (1B) and limitation of inspiratory plateau pressure strategy (1C) for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS); application of at least a minimal amount of positive end-expiratory pressure in acute lung injury (1C); head of bed elevation in mechanically ventilated patients unless contraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease days of mechanical ventilation and ICU length of stay, a conservative fluid strategy for patients with established ALI/ARDS who are not in shock (1C); protocols for weaning and sedation/analgesia (1B); using either intermittent bolus sedation or continuous infusion sedation with daily interruptions or lightening (1B); avoidance of neuromuscular blockers, if at all possible (1B); institution of glycemic control (1B) targeting a blood glucose < 150 mg/dL after initial stabilization ( 2C ); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophylaxis for deep vein thrombosis (1A); use of stress ulcer prophylaxis to prevent upper GI bleeding using H2 blockers (1A) or proton pump inhibitors (1B); and consideration of limitation of support where appropriate (1D). Recommendations specific to pediatric severe sepsis include: greater use of physical examination therapeutic end points (2C); dopamine as the first drug of choice for hypotension (2C); steroids only in children with suspected or proven adrenal insufficiency (2C); a recommendation against the use of recombinant activated protein C in children (1B).

Conclusion: There was strong agreement among a large cohort of international experts regarding many level 1 recommendations for the best current care of patients with severe sepsis. Evidenced-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improved outcomes for this important group of critically ill patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Approach to Pediatric Shock
See this image and copyright information in PMC

Comment in

Similar articles

  • Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Dellinger RP, et al. Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41. Crit Care Med. 2008. PMID: 18158437
  • Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.
    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Dellinger RP, et al. Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30. Intensive Care Med. 2013. PMID: 23361625 Free PMC article.
  • Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Dellinger RP, et al. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941
  • Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.
    Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee. Dellinger RP, et al. Crit Care Med. 2004 Mar;32(3):858-73. doi: 10.1097/01.ccm.0000117317.18092.e4. Crit Care Med. 2004. PMID: 15090974
  • [Protocol of the management of patients with severe sepsis and septic shock].
    Nakashidze IM, Tsintsadze NG, Potskhishvili ShN. Nakashidze IM, et al. Georgian Med News. 2012 Nov;(212):40-5. Georgian Med News. 2012. PMID: 23221137 Review. Russian.
See all similar articles

Cited by

See all "Cited by" articles

References

Introduction and Methods

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11445675', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11445675/'}]}
    2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12627010', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12627010/'}]}
    2. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31:946–955 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12700374', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12700374/'}]}
    2. Martin GS, Mannino DM, Eaton S, Moss M (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC522859', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC522859/'}, {'type': 'PubMed', 'value': '15312201', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15312201/'}]}
    2. Linde-Zwirble WT, Angus DC (2004) Severe sepsis epidemiology: sampling, selection, and society. Crit Care 8:222–226 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '17414736', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17414736/'}]}
    2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1414–1415 - PubMed

Initial Resuscitation

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11794169', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11794169/'}]}
    2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12536268', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12536268/'}]}
    2. Bendjelid K, Romand JA (2003) Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med 29:352–360 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15758597', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15758597/'}]}
    2. Malbrain ML, Deeren D, De Potter TJ (2005) Intra-abdominal hypertension in the critically ill: It is time to pay attention. Curr Opin Crit Care 11:156–171 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15973520', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15973520/'}]}
    2. Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettilä V (2005) Hemodynamic variables related to outcome in septic shock. Intensive Care Med 31:1066–1071 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16484902', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16484902/'}]}
    2. Kortgen A, Niederprum P, Bauer M (2006) Implementation of an evidence-based “standard operating procedure” and outcome in septic shock. Crit Care Med 34:943–949 - PubMed

Diagnosis

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '6828811', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/6828811/'}]}
    2. Weinstein MP, Reller LP, Murphy JR, Lichtenstein KA (1983) The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5:35–53 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC124817', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC124817/'}, {'type': 'PubMed', 'value': '9431930', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9431930/'}]}
    2. Blot F, Schmidt E, Nitenberg G, Tancrède C, Laplanche A, Andremont A (1998) Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 36:105–109 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8328734', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8328734/'}]}
    2. Mermel LA, Maki DG (1993) Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 119:270–272 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15699079', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15699079/'}]}
    2. American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15484175', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15484175/'}]}
    2. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, Voros D, Mandragos K, Giamarellou H (2004) Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care 19:152–157 - PubMed

Antibiotic Therapy

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16625125', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16625125/'}]}
    2. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1195428', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1195428/'}, {'type': 'PubMed', 'value': '16127033', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16127033/'}]}
    2. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14699449', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14699449/'}]}
    2. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE, Infectious Diseases Society of America (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189 - PubMed
    1. None
    2. McCabe WR, Jackson GG (1962) Gram negative bacteremia. Arch Intern Med 110:92–100
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '6987871', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/6987871/'}]}
    2. Kreger BE, Craven DE, McCabe WR (1980) Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68:344–355 - PubMed

Source Control

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11307370', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11307370/'}]}
    2. Jimenez MF, Marshall JC (2001) Source control in the management of sepsis. Intensive Care Med 27:S49–S62 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8863251', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8863251/'}]}
    2. Moss RL, Musemeche CA, Kosloske AM (1996) Necrotizing fascitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 31:1142–1146 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8950379', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8950379/'}]}
    2. Bufalari A, Giustozzi G, Moggi L (1996) Postoperative intraabdominal abscesses: Percutaneous versus surgical treatment. Acta Chir Belg 96:197–200 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12233868', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12233868/'}]}
    2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR 51(RR-10):1–29 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '0', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/0/'}]}
    2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA, Healthcare Infection Control Practices Advisory Committee (2002) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35:1281–1307 - PubMed

Fluid Therapy

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15163774', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15163774/'}]}
    2. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9934917', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9934917/'}]}
    2. Choi PTL, Yip G, Quinonez LG, Cook DJ (1999) Crystalloids vs. colloids in fluid resuscitation: A systematic review. Crit Care Med 27:200–210 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11487488', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11487488/'}]}
    2. Cook D, Guyatt G (2001) Colloid use for fluid resuscitation: Evidence and spin. Ann Intern Med 135:205–208 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC28497', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC28497/'}, {'type': 'PubMed', 'value': '9550953', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9550953/'}]}
    2. Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: Asystematic review of randomized trials. BMJ 316:961–964 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11289347', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11289347/'}]}
    2. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916 - PubMed

Vasopressors

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15343024', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15343024/'}]}
    2. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928–1948 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10966242', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10966242/'}]}
    2. LeDoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:2729–32 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8404107', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8404107/'}]}
    2. Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103:1826–1831 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10966247', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10966247/'}]}
    2. Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758–2765 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12794401', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12794401/'}]}
    2. De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 31:1659–1667 - PubMed

Inotropic Therapy

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7675044', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7675044/'}]}
    2. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333:1025–1032 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7993413', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7993413/'}]}
    2. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330:1717–1722 - PubMed

Steroids

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12186604', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12186604/'}]}
    2. Annane D, Sebille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10321661', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10321661/'}]}
    2. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9559600', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9559600/'}]}
    2. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650 - PubMed
    1. None
    2. Sprung CL, Annane D, Briegel J, Keh D, Moreno R, Singer M, Weiss Y, Sorenson F (2007) Corticosteroid therapy of septic shock (CORTICUS) (abstract). Am Rev Resp Crit Care Med 175:A507
    1. None
    2. Briegel J, Vogeser M, Annane D, Keh D, Moreno R, Singer M, Weiss Y, Sprung CL (2007) Measurement of cortisol in septic shock: Interlaboratory harmonization. Am Rev Resp Crit Care Med 175:A436

Recombinant Human Activated Protein C

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11236773', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11236773/'}]}
    2. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 344:699–709 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16192478', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16192478/'}]}
    2. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL, Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332–1341 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16215381', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16215381/'}]}
    2. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 33:2266–2277 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1530753', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1530753/'}]}
    2. Oxman AD, Guyatt GH (1992) A consumer's guide to subgroup analyses. Ann Intern Med 116:78–84 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12544987', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12544987/'}]}
    2. Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR (2003) Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 31:12–19 - PubMed

Blood Product Administration

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9971864', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9971864/'}]}
    2. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion in critical care. N Engl J Med 340:409–417 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8501845', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8501845/'}]}
    2. Marik PE, Sibbald WJ (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269:3024–3029 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8370294', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8370294/'}]}
    2. Lorente JA, Landín L, dePablo R, Renes E, Rodriguez-Diaz R, Liste D (1993) Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 21:1312–1318 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC83858', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC83858/'}, {'type': 'PubMed', 'value': '11737926', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11737926/'}]}
    2. Fernandes CJ Jr, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E (2001) Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 5:362–567 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10579246', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10579246/'}]}
    2. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized double-blind, placebo-controlled trial. Crit Care Med 27:2346–2350 - PubMed

Mechanical Ventilation

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10793162', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10793162/'}]}
    2. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9449727', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9449727/'}]}
    2. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9847275', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9847275/'}]}
    2. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondejar E, Clementi E, Mancebo J, Factor P, Matamis D, Ranieri M, Blanch L, Rodi G, Mentec H, Dreyfuss D, Ferrer M, Brun-Buisson C, Tobin M, Lemaire F (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 158:1831–1838 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10470755', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10470755/'}]}
    2. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P Jr, Wiener CM, Teeter JG, Dodd-o JM, Almog Y, Piantadosi S (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27:1492–1498 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9449728', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9449728/'}]}
    2. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, Mazer CD, McLean RF, Rogovein TS, Schouten BD, Todd TR, Slutsky AS (1998) Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 338:355–361 - PubMed

Sedation, Analgesia and Neuromuscular Blockade

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10628598', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10628598/'}]}
    2. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27:2609–2615 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10217225', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10217225/'}]}
    2. Marx WH, DeMaintenon NL, Mooney KF, Mascia ML, Medicis J, Franklin PD, Sivak E, Rotello L (1999) Cost reduction and outcome improvement in the intensive care unit. J Trauma 46:625–629 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10853622', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10853622/'}]}
    2. MacLaren R, Plamondon JM, Ramsay KB, Rocker GM, Patrick WD, Hall RI (2000) A prospective evaluation of empiric versus protocol-based sedation and analgesia. Pharmacotherapy 20:662–672 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10823383', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10823383/'}]}
    2. De Jonghe B, Cook D, Appere-De-Vecchi C, Guyatt G, Meade M, Outin H (2000) Using and understanding sedation scoring systems: a systematic review. Intensive Care Med 20:662–672 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10446819', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10446819/'}]}
    2. Devlin JW, Boleski G, Mlynarek M, Nerenz DR, Peterson E, Jankowski M, Horst HM, Zarowitz BJ (1999) Motor activity assessment scale: A valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med 27:1271–1275 - PubMed

Glucose Control

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11794168', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11794168/'}]}
    2. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med 345:1359–1367 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16452557', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16452557/'}]}
    2. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive Insulin Therapy in the Medical ICU. N Engl J Med 354:449–461 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15301325', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15301325/'}]}
    2. Krinsley JS (2004) Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients. Mayo Clin Proc 79:992–1000 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14559958', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14559958/'}]}
    2. Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose Control and Mortality in Critically Ill Patients. JAMA 290:2041–2047 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14661676', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14661676/'}]}
    2. Krinsley JS (2003) Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients. Mayo Clin Proc 78:1471–1478 - PubMed

Renal Replacement

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3752430', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3752430/'}]}
    2. Mauritz W, Sporn P, Schindler I, Zadrobilek E, Roth E, Appel W (1986) Acute renal failure in abdominal infection. Comparison of hemodialysis and continuous arteriovenous and continuous hemofiltration. Anasth Intensivther Nortfallmed 21:212–217 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3090725', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3090725/'}]}
    2. Bartlett RH, Mault JR, Dechert RE, Palmer J, Swartz RD, Port FK (1986) Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure. Surgery 100:400–408 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1802555', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1802555/'}]}
    2. Kierdorf H (1991) Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib Nephrol 93:1–12 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1457942', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1457942/'}]}
    2. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N (1992) Acute renal failure in critical illness: conventional dialysis versus continuous hemodiafiltration. Am Soc Artif Intern Organs J 38:M654–M657 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8538850', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8538850/'}]}
    2. Bellomo R, Farmer M, Parkin G, Wright C, Boyce N (1995) Severe acute renal failure: a comparison of acute continuous hemodilafiltration and conventional dialytic therapy. Nephron 71:59–64 - PubMed

Bicarbonate Therapy

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2156475', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2156475/'}]}
    2. Cooper DJ, Walley KR, Wiggs BR, Russell JA (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 112:492–498 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1935152', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1935152/'}]}
    2. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19:1352–1356 - PubMed

DVT Prophylaxis

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7044682', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7044682/'}]}
    2. Cade JF (1982) High risk of the critically ill for venous thromboembolism. Crit Care Med 10:448–450 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '6971738', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/6971738/'}]}
    2. Pingleton SK, Bone RC, Pingleton WW, Ruth WE (1981) Prevention of pulmonary emboli in a respiratory intensive care unit. Chest 79:647–650 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7073148', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7073148/'}]}
    2. Halkin H, Goldberg J, Modan M, Modan B (1982) Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 96:561–565 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7291971', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7291971/'}]}
    2. Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26:115–117 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8637340', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8637340/'}]}
    2. Gardlund B (1996) Randomized, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases: The Heparin Prophylaxis Study Group. Lancet 347:1357–1361 - PubMed

Stress Ulcer Prophylaxis

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7011078', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7011078/'}]}
    2. Basso N, Bagarani M, Materia A, Fiorani S, Lunardi P, Speranza V (1981) Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Am J Surg 141:339–342 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3499074', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3499074/'}]}
    2. Bresalier RS, Grendell JH, Cello JP, Meyer AA (1987) Sucralfate versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 83:110–116 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3946364', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3946364/'}]}
    2. Poleski MH, Spanier AH (1986) Cimetidine versus antacids in the prevention of stress erosions in critically ill patients. Am J Gastroenterol 81:107–111 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1344847', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1344847/'}, {'type': 'PubMed', 'value': '7406571', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7406571/'}]}
    2. Stothert JC Jr, Simonowitz DA, Dellinger EP, Farley M, Edwards WA, Blair AD, Cutler R, Carrico CJ (1980) Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 192:169–174 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8284001', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8284001/'}]}
    2. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. (1994) Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 330:377–381 - PubMed

SDD References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1681223', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1681223/'}]}
    2. Vandenbroucke-Grauls CMJ, Vandenbroucke JP (1991) Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 338:859–862 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1678619', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1678619/'}, {'type': 'PubMed', 'value': '8400971', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8400971/'}]}
    2. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group (1993) Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 307:525–532 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8162733', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8162733/'}]}
    2. Kollef M (1994) The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest 105:1101–1108 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8018162', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8018162/'}]}
    2. Heyland DK, Cook DJ, Jaeschke R, Griffith L, Lee HN, Guyatt GH (1994) Selective decontamination of the digestive tract: an overview. Chest 105:1221–1229 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC162658', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC162658/'}, {'type': 'PubMed', 'value': '7786000', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7786000/'}]}
    2. Hurley JC (1995) Prophylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection? Antimicrob Agents Chemother 39:941–947 - PMC - PubMed

Consideration for Limitation of Support

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16499459', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16499459/'}]}
    2. Curtis JR (2005) Interventions to improve care during withdrawal of life-sustaining treatments. J Palliative Medicine (Suppl 1) 8:S116–31 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15286559', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15286559/'}]}
    2. Thompson BT, Cox PN, Antonelli M, Carlet JM, Cassell J, Hill NS, Hinds CJ, Pimentel JM, Reinhart K, Thijs LG, American Thoracic Society, European Respiratory Society, European Society of Intensive Care Medicine, Society of Critical Care Medicine, Sociètède Rèanimation de Langue Française (2004) Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: executive summary. Crit Care Med 32:1781–1784 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12640606', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12640606/'}]}
    2. Heyland DK, Tranmer J, O'Callaghan CJ, Gafni A (2003) The Seriously Ill Patient: Preferred Role in End of Life Decision Making. J Crit Care 18:3–10 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15640361', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15640361/'}]}
    2. Curtis JR, Engelberg RA, Wenrich MD, Shannon SE, Treece PD, Rubenfeld GD (2005) Missed opportunities during family conferences about end-of-life care in the intensive care unit. Am J Resp Crit Care Med 171:844–849 - PubMed

Pediatric Considerations

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12433670', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12433670/'}]}
    2. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167:695–701 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15636651', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15636651/'}]}
    2. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1717850', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1717850/'}, {'type': 'PubMed', 'value': '10325716', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10325716/'}]}
    2. Pollard AJ, Britto J, Nadel S, DeMunter C, Habibi P, Levin M (1999) Emergency management of meningococcal disease. Arch Dis Child 80:290–296 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15985474', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15985474/'}]}
    2. den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC (2005) Adrenal insufficiency in meningococcal sepsis: Bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. Clin Endocrinol Metab 90:5110–5117 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '3946322', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3946322/'}]}
    2. Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA (1986) Pediatric emergency intravenous access. Evaluation of a protocol. Am J Dis Child 140:132–134 - PubMed

Summary and Future Directions

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16943730', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16943730/'}]}
    2. Cinel I, Dellinger RP (2006) Guidelines for severe infections: are they useful. Curr Opin Crit Care 12:483–488 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15542969', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15542969/'}]}
    2. Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, Ramsay G (2004) Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med [Suppl] 32:S595–S597 - PubMed

Appendicies

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '17426195', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17426195/'}]}
    2. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 131:1954–1963 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16625008', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16625008/'}]}
    2. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684 - PubMed

Publication types